Paraoxonase: a multifaceted biomolecule
B Goswami, D Tayal, N Gupta, V Mallika - Clinica Chimica Acta, 2009 - Elsevier
BACKGROUND: Paraoxonase enzyme was first identified as a protective barrier against
organophosphorus poisoning. After painstaking research spanning the last three decades …
organophosphorus poisoning. After painstaking research spanning the last three decades …
Antioxidant mechanisms in nonalcoholic fatty liver disease
W Liu, SS Baker, RD Baker, L Zhu - Current drug targets, 2015 - ingentaconnect.com
Nonalcoholic fatty liver disease (NAFLD) represents a broad spectrum of histological
abnormalities with clinical presentations ranging from hepatic steatosis to nonalcoholic …
abnormalities with clinical presentations ranging from hepatic steatosis to nonalcoholic …
Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment
G Baskol, H Atmaca, F Tanrıverdi… - Experimental and …, 2007 - thieme-connect.com
The present study was designed to investigate the relationship between the serum levels of
oxidant-antioxidant system (malondialdehyde (MDA) level, Paraoxonase (PON1) activity …
oxidant-antioxidant system (malondialdehyde (MDA) level, Paraoxonase (PON1) activity …
[HTML][HTML] Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD
N Alkhouri, AJ McCullough - Gastroenterology & hepatology, 2012 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in
the United States, affecting an estimated 70 million Americans. The histologic spectrum of …
the United States, affecting an estimated 70 million Americans. The histologic spectrum of …
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
G Baskol, M Baskol, D Kocer - Clinical Biochemistry, 2007 - Elsevier
OBJECTIVES:: Oxidative stress is an important pathophysiological mechanism in non-
alcoholic steatohepatitis (NASH). We aimed to evaluate serum xanthine oxidase (XO)(as a …
alcoholic steatohepatitis (NASH). We aimed to evaluate serum xanthine oxidase (XO)(as a …
Advances in noninvasive biomarkers for nonalcoholic fatty liver disease
GE Gîlcă-Blanariu, DS Budur, DE Mitrică, E Gologan… - Metabolites, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) currently represents one of the most common liver
diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly …
diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly …
Paraoxonase 1 and non-alcoholic fatty liver disease: a meta-analysis
K Kotani, J Watanabe, K Miura, A Gugliucci - Molecules, 2021 - mdpi.com
Oxidative stress is involved in the pathophysiology of nonalcoholic fatty liver disease
(NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not …
(NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not …
Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
MV Milaciu, ȘC Vesa, IC Bocșan… - Journal of clinical …, 2019 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) is an important cause of chronic liver
diseases around the world. Paraoxonase-1 (PON1) is an enzyme produced by the liver with …
diseases around the world. Paraoxonase-1 (PON1) is an enzyme produced by the liver with …
OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease
Abstract Background and Aim Oxidative stress is a core abnormality responsible for disease
progression in nonalcoholic fatty liver disease (NAFLD). By employing a highly sensitive …
progression in nonalcoholic fatty liver disease (NAFLD). By employing a highly sensitive …
Systematic review of performance of non‐invasive biomarkers in the evaluation of non‐alcoholic fatty liver disease
This systematic review evaluates the many studies carried out to discover and evaluate non‐
invasive markers of non‐alcoholic fatty liver disease (NAFLD). Many different strategies and …
invasive markers of non‐alcoholic fatty liver disease (NAFLD). Many different strategies and …